ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

PRAXBIND
Bleeding disorders
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

PRAXBIND Rx

Generic Name and Formulations:
Idarucizumab 2.5g/50mL; soln for IV infusion; preservative-free; contains sorbitol.

Company:
Boehringer Ingelheim Pharmaceuticals

Therapeutic Use:

Indications for PRAXBIND:

Reversal of the anticoagulant effects of dabigatran in emergency surgery/urgent procedures and in life-threatening or uncontrolled bleeding.

Adult:

For IV use only. Administer 5g (2 vials) as 2 consecutive infusions or as bolus injection of both vials consecutively via syringe. Other additional dose: see Warnings/Precautions.

Children:

Not established.

Warnings/Precautions:

Thromboembolic risk; consider resuming anticoagulant therapy as soon as medically appropriate; can initiate dabigatran 24hrs after Praxbind administration. In patients having a reappearance of bleeding with elevated coagulation parameters or those requiring a second emergency surgery/urgent procedure and have elevated coagulation parameters, consider repeat administration of Praxbind 5g dose. Discontinue immediately if hypersensitivity reactions occur and treat appropriately. Hereditary fructose intolerance. Pregnancy. Nursing mothers.

Pharmacological Class:

Humanized monoclonal antibody fragment.

Adverse Reactions:

Headache, hypokalemia, delirium, constipation, pyrexia, pneumonia; hypersensitivity.

Generic Availability:

NO

How Supplied:

Single-use vials—2

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs